Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008:1:60-63.
doi: 10.2174/1874769800801010060.

Imaging Mouse Prostate Gland by 3 Tesla Clinical MRI System

Affiliations

Imaging Mouse Prostate Gland by 3 Tesla Clinical MRI System

A M Rad et al. Open Magn Reson Rev. 2008.

Abstract

In vivo detection of prostate tumor in animal model will facilitate the investigations that deal with the efficacy of different treatment strategies in different experimental settings. Recently higher field strength dedicated animal MRI system has been used successfully to detect mouse prostate glands and its lesions, however, usefulness of clinical system has not been utilized to its fullest extent. In this short communication we show the advantages and disadvantages of different in vivo imaging parameters of MRI to acquire images of the mouse prostate gland using clinical strength MRI systems.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Schematic illustration of mouse urogenital systems adapted from “The Anatomy of the Laboratory Mouse by Margaret J. Cook, M.R.C. Laboratory Animals Centre, Carshalton, Surrey, England Academic Press, 1965” with permission. Copyright Elsevier.
Fig. 2
Fig. 2. Identification of mouse prostate gland on MRI
The images were obtained by a 3 tesla MRI system using 50×108 mm Litzcage volume coil by Doty Scientific, using following imaging parameters: fast spin echo FATSAT T2-weighted sequence, TR/TE = 2000/13–15 ms, 25 to 30 mm FOV, 128×128 matrices, NEX = 3, slice thickness 0.7 to 0.9 mm. (A) axial, (B,C) sagittal, (D,E) coronal sections are showing prostate gland (white arrows). b = urinary bladder, t = testes. White arrows indicate the prostate gland. Arrow heads (B,E) indicate the preputial gland.
Fig. 3
Fig. 3. Advantage of T2-weighted over T1-weighted images
(A) Axial T1-weighted image obtained using following parameters: TR/TE = 300/10 ms, 40×40 mm FOV, 128×128 matrices, NEX = 2. (B) Axial FSE fatsat T2-weighted image obtained using following parameters: TR/TE = 1800/13 ms, 25×25 mm FOV, 128×128 matrices, NEX = 4, slice thickness 0.7 mm. Note the clear demarcation of prostate gland on T2-weighted image (white arrows). b = urinary bladder.
Fig. 4
Fig. 4. Advantages of FATSAT and longer TE for T2-weighted images
(A) Axial FSE T2-weighted image obtained using following parameters: TR/TE = 3850/12 ms, 30×30 mm FOV, 128×128 matrices, NEX = 3, slice thickness 1.2 mm. (B) FATSAT axial FSE T2-weighted image obtained at the same plane using following parameters: TR/TE = 3850/12 ms, 30×30 mm FOV, 128×128 matrices, NEX = 3, slice thickness 1.2 mm. Note the clear demarcation of the prostate gland on FATSAT T2-weighted image (white arrow). (C) FATSAT T2-weighted image obtained with short TE (20 ms) and (D) longer TE (40 ms) using similar parameters indicated above in A and B. b = urinary bladder, t = testes. Arrow heads (C,D) indicate preputial gland.
Fig. 5
Fig. 5. Detection of implanted tumor in the left dorsolateral lobe of prostate by in vivo MRI
Tumors are shown in axial (A, B), coronal (C, D) and sagittal (E,F) planes. FATSAT T2-weighted images were obtained with short TE (12–13 ms, A, C and E) and long TE (69–73 ms, B, D and F). Note the better demarcation of tumor on images with long TE (arrows). b = urinary bladder, t = testes. White arrows indicate the tumor in prostate gland. Arrow heads (D) indicate preputial gland.
Fig. 6
Fig. 6. Measurement of tumor and prostate gland
Tumor is outlined on axial, sagittal and coronal plans (A-D) indicating accurate demacation of tumor from normal prostate gland. Length of prostate gland including tumor (8 mm), length (6.5 mm) and width (5 mm) of the implanted tumor alone are shown (E), which are comparable to the tumor bearing extracted gland (F).

References

    1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA: a cancer journal for clinicians. 2008;58(2):71–96. - PubMed
    1. Gupta S, Ahmad N, Marengo SR, MacLennan GT, Greenberg NM, Mukhtar H. Chemoprevention of prostate carcinogenesis by alpha-difluoromethylornithine in TRAMP mice. Cancer research. 2000;60(18):5125–33. - PubMed
    1. Gupta S, Hastak K, Ahmad N, Lewin JS, Mukhtar H. Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proceedings of the National Academy of Sciences of the United States of America. 2001;98(18):10350–5. - PMC - PubMed
    1. Fricke ST, Rodriguez O, Vanmeter J, Dettin LE, Casimiro M, Chien CD, Newell T, Johnson K, Ileva L, Ojeifo J, Johnson MD, Albanese C. In vivo magnetic resonance volumetric and spectroscopic analysis of mouse prostate cancer models. The Prostate. 2006;66(7):708–17. - PubMed
    1. Degrassi A, Russo M, Scanziani E, Giusti A, Ceruti R, Texido G, Pesenti E. Magnetic resonance imaging and histopathological characterization of prostate tumors in TRAMP mice as model for pre-clinical trials. The Prostate. 2007;67(4):396–404. - PubMed

LinkOut - more resources